These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
    Author: Amin MM, Ban TA, Pecknold JC, Klingner A.
    Journal: J Int Med Res; 1977; 5 Suppl 5():33-7. PubMed ID: 340305.
    Abstract:
    In a comparative study of three treatment regimens in patients with obsessive-compulsive or phobic manifestations, the most favourable therapeutic findings were seen in the clomipramine (Anafranil, Geigy Pharmaceuticals) plus behaviour therapy group and the least favourable therapeutic findings in the clomipramine plus simulated behaviour therapy group. The findings that a combination of behaviour therapy and clomipramine results in more favourable therapeutic changes than either of the two treatments alone is in line with reported studies in the literature.
    [Abstract] [Full Text] [Related] [New Search]